Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies
Crossref DOI link: https://doi.org/10.1186/s13075-016-1188-6
Published Online: 2016-12-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cooles, Faye A. H.
Anderson, Amy E.
Drayton, Tracey
Harry, Rachel A.
Diboll, Julie
Munro, Lee
Thalayasingham, Nishanthi
Östör, Andrew J. K.
Isaacs, John D.
Funding for this research was provided by:
Genzyme (GZ - 2011 -10841)
